Ö. ERSOY, "Dihydropyrimidine dehydrogenase deficiency:probabable cause for the lethal toxicity of capacitabine and 5 -FU therapy in a patient with rectal cancer- case report.," International symposium on advances in predictive personalised medicine , İstanbul, Turkey, 2015
ERSOY, Ö. 2015. Dihydropyrimidine dehydrogenase deficiency:probabable cause for the lethal toxicity of capacitabine and 5 -FU therapy in a patient with rectal cancer- case report.. International symposium on advances in predictive personalised medicine , (İstanbul, Turkey).
ERSOY, Ö., (2015). Dihydropyrimidine dehydrogenase deficiency:probabable cause for the lethal toxicity of capacitabine and 5 -FU therapy in a patient with rectal cancer- case report. . International symposium on advances in predictive personalised medicine, İstanbul, Turkey
ERSOY, Özdal. "Dihydropyrimidine dehydrogenase deficiency:probabable cause for the lethal toxicity of capacitabine and 5 -FU therapy in a patient with rectal cancer- case report.," International symposium on advances in predictive personalised medicine, İstanbul, Turkey, 2015
ERSOY, Özdal. "Dihydropyrimidine dehydrogenase deficiency:probabable cause for the lethal toxicity of capacitabine and 5 -FU therapy in a patient with rectal cancer- case report.." International symposium on advances in predictive personalised medicine , İstanbul, Turkey, 2015
ERSOY, Ö. (2015) . "Dihydropyrimidine dehydrogenase deficiency:probabable cause for the lethal toxicity of capacitabine and 5 -FU therapy in a patient with rectal cancer- case report.." International symposium on advances in predictive personalised medicine , İstanbul, Turkey.
@conferencepaper{conferencepaper, author={Özdal ERSOY}, title={Dihydropyrimidine dehydrogenase deficiency:probabable cause for the lethal toxicity of capacitabine and 5 -FU therapy in a patient with rectal cancer- case report.}, congress name={International symposium on advances in predictive personalised medicine}, city={İstanbul}, country={Turkey}, year={2015}}